The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 2991087)

Published in Clin Transpl on January 01, 1995

Authors

R Shapiro1, M L Jordan, V P Scantlebury, C Vivas, H A Gritsch, R J Corry, F Egidi, J McCauley, D Ellis, N Gilboa

Author Affiliations

1: University of Pittsburgh, School of Medicine, Pittsburgh Transplantation Institute, Pennsylvania, USA.

Articles cited by this

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Kidney transplantation under FK 506. JAMA (1990) 7.45

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13

Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation (1995) 2.67

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50

A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49

The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation (1987) 2.40

FK 506 in clinical kidney transplantation. Transplant Proc (1991) 2.29

The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation (1995) 2.13

A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation (1995) 2.09

The side effects of FK 506 in humans. Transplant Proc (1990) 2.08

Small intestinal transplantation in humans with or without the colon. Transplantation (1994) 1.74

Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. Transplant Proc (1993) 1.72

Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group. Transplant Proc (1995) 1.70

The question of FK 506 nephrotoxicity after liver transplantation. Transplant Proc (1991) 1.60

New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc (1991) 1.56

Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients. Transplantation (1989) 1.49

FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc (1991) 1.37

Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg (1994) 1.33

The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine. Am J Surg Pathol (1993) 1.32

A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation. Transplantation (1994) 1.30

Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells. Transplant Proc (1995) 1.24

Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients. Am J Kidney Dis (1988) 1.21

Combined kidney/bone marrow transplantation--evidence of augmentation of chimerism. Transplantation (1995) 1.19

The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation. Transplant Proc (1991) 1.16

A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy. Clin Transplant (1994) 1.15

A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. Transplant Proc (1995) 1.13

FK506 in pediatric kidney transplantation--primary and rescue experience. Pediatr Nephrol (1995) 1.11

FK 506 versus cyclosporine. Transplant Proc (1993) 1.03

Histopathology of human renal allograft rejection under FK 506: a comparison with cyclosporine. Transplant Proc (1991) 1.02

Combined bone marrow and whole organ transplantation from the same donor. Transplant Proc (1994) 1.02

Phase II study of FK 506 for allogeneic bone marrow transplantation. Transplant Proc (1991) 0.90

FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation. Transplant Proc (1991) 0.89

Phase II FK 506 multicenter concentration control study: one-year follow-up. Transplant Proc (1995) 0.89

Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients. Diabetes (1993) 0.86

Pediatric kidney transplantation at the University of Pittsburgh. Transplant Proc (1994) 0.86

Improving results of pediatric renal transplantation. J Am Coll Surg (1994) 0.82

Phase III study of FK 506 in kidney transplantation. Japanese FK 506 Study Group. Transplant Proc (1995) 0.81

Kidney/Bone Marrow Transplantation. Dial Transplant (1996) 0.76

Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients. Transplantation (1994) 0.76

FK 506: long-term study in kidney transplantation. Japanese FK 506 Study Group. Transplant Proc (1995) 0.76

Articles by these authors

Kidney transplantation under FK 506. JAMA (1990) 7.45

Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation (1973) 6.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

The effects of external cations and ouabain on the intracellular sodium activity of sheep heart Purkinje fibres. J Physiol (1977) 3.82

Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis (2000) 3.71

Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy. Antimicrob Agents Chemother (2000) 3.54

Direct measurement of the intracellular pH of mammalian cardiac muscle. J Physiol (1976) 3.41

The Arabidopsis NIM1 protein shows homology to the mammalian transcription factor inhibitor I kappa B. Plant Cell (1997) 3.40

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Consensus statement on the live organ donor. JAMA (2000) 3.29

Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes (1990) 3.07

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol (2010) 2.89

Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited. Arch Intern Med (1997) 2.79

Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J Virol (2001) 2.76

Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. Lancet (1990) 2.66

Interactions between the regulation of the intracellular pH and sodium activity of sheep cardiac Purkinje fibres. J Physiol (1980) 2.60

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50

Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant (2006) 2.48

Intracellular calcium and sodium activity in sheep heart Purkinje fibres. Effect of changes of external sodium and intracellular pH. Pflugers Arch (1982) 2.45

Characterization of influenza virus RNA complete transcripts. Virology (1982) 2.31

FK 506 in clinical kidney transplantation. Transplant Proc (1991) 2.29

The intracellular sodium activity of cardiac Purkinje fibres during inhibition and re-activation of the Na-K pump. J Physiol (1978) 2.25

Induction kinetics of the L-arabinose operon of Escherichia coli. J Bacteriol (1973) 2.23

Prevalence of urinary tract infection in febrile infants. J Pediatr (1993) 2.12

A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation (1995) 2.09

A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Global Antifungal Surveillance Group. Diagn Microbiol Infect Dis (2000) 1.99

Heart transplantation in congenic strains of mice. Transplant Proc (1973) 1.97

FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood. Lancet (1990) 1.94

Changes in the intracellular sodium activity of sheep heart Purkinje fibres produced by calcium and other divalent cations. J Physiol (1978) 1.93

Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation (1999) 1.93

Virulence, serotype, and molecular characteristics of environmental strains of Cryptococcus neoformans var. gattii. Infect Immun (1992) 1.86

Influenza virus RNA segment 7 has the coding capacity for two polypeptides. Virology (1980) 1.80

Sequence analysis of insecticidal genes from Xenorhabdus nematophilus PMFI296. Appl Environ Microbiol (2001) 1.78

Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. Transplant Proc (1993) 1.72

Acute flank pain and reversible renal dysfunction associated with nonsteroidal anti-inflammatory drug use. Pediatrics (1993) 1.71

Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I. Diabetes Care (1990) 1.70

Hepatic artery thrombosis after pediatric liver transplantation--a medical or surgical event? Transplantation (1989) 1.67

Evaluation of a commercial ELISA for detecting Norwalk-like virus antigen in faeces. J Clin Virol (2003) 1.65

Hereditary demyelinating neuropathy of infancy. A genetically complex syndrome. Brain (1997) 1.65

Nucleotide sequences at the terminal of La Crosse virus RNAs. Nucleic Acids Res (1980) 1.61

Nurses' attitudes toward death and caring for dying patients. Oncol Nurs Forum (1999) 1.58

Environmental isolation of Cryptococcus neoformans gattii from California. J Infect Dis (1991) 1.57

New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc (1991) 1.56

Information in primary health care. Health Libr Rev (1995) 1.56

Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology (2005) 1.56

Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation. Pediatr Nephrol (1994) 1.55

Positive-outcome bias: comparison of emergency medicine and general medicine literatures. Acad Emerg Med (1995) 1.55

Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Proc Natl Acad Sci U S A (1999) 1.54

Sodium-dependent control of intracellular pH in Purkinje fibres of sheep heart. J Physiol (1985) 1.50

Surgical treatment of acute necrotizing pancreatitis. Ann Surg (1970) 1.49

An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant (2001) 1.48

Pancreas transplantation with enteric drainage under tacrolimus induction therapy. Transplant Proc (1997) 1.48

Technique of simultaneous renal pancreatoduodenal transplantation with urinary drainage of pancreatic secretion. Am J Surg (1987) 1.46

Congenital rubella in the Asian community in Britain. BMJ (1990) 1.46

Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation (1992) 1.45

Doubts using family history, age, alpha-fetoprotein and total human chorionic gonadotrophin in screening for Down's syndrome. Br J Obstet Gynaecol (1994) 1.43

One-dose antibiotic prophylaxis against wound infection after appendicectomy: a randomized trial of clindamycin, cefazolin sodium and a placebo. Br J Surg (1979) 1.43

Endoscopic polypectomy: inadequate treatment for invasive colorectal carcinoma. Ann Surg (1981) 1.42

Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41

The Substance Abuse Consultation Team. Addressing the problem of hospitalized substance abusers. Gen Hosp Psychiatry (1994) 1.41

Microelectrode measurement of the intracellular pH of mammalian heart cells. Nature (1976) 1.41

Change in knowledge of midwives and obstetricians following obstetric emergency training: a randomised controlled trial of local hospital, simulation centre and teamwork training. BJOG (2007) 1.41

Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J Leukoc Biol (1993) 1.40

Obstetric care in rural Missouri: the loss of rural general and family practitioners. Mo Med (1990) 1.38

A new method of construction of obturators for nasal septal perforations and evidence of outcomes. Clin Otolaryngol (2007) 1.38

FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc (1991) 1.37

Surgical treatment of diabetic nephropathy with simultaneous pancreatic duodenal and renal transplantation. Surg Gynecol Obstet (1986) 1.35

Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care (1993) 1.32

The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine. Am J Surg Pathol (1993) 1.32

Coronary artery disease in IDDM. Gender differences in risk factors but not risk. Arterioscler Thromb Vasc Biol (1996) 1.31

Trephine air drill, bronchial brush, and fiberoptic transbronchial lung biopsies in immunosuppressed patients. Am Rev Respir Dis (1977) 1.31

Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin. J Clin Microbiol (2007) 1.30

Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. Clin Microbiol Infect (2009) 1.28

BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis (1995) 1.28

Serum creatine phosphokinase in normal newborns. Arch Dis Child (1976) 1.27

Apoptosis in procyclic Trypanosoma brucei rhodesiense in vitro. Cell Death Differ (1996) 1.27

New approach to evaluation of proteinuric states. Clin Chem (1977) 1.26

The relationship between the intra- and extracellular sodium activity of sheep heart Purkinje fibres during inhibition of the Na-K pump. Pflugers Arch (1978) 1.24

Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. Ann Surg (1999) 1.24

Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin Microbiol Infect (2009) 1.24

Cardiovascular autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes. Incidence and predictors. J Diabetes Complications (2000) 1.23

Oxygen free radical induced damage in kidneys subjected to warm ischemia and reperfusion. Protective effect of superoxide dismutase. Ann Surg (1985) 1.22

Crystal engineering with heteroboranes. I. 1-Carboxy-1,2-dicarba-closo-dodecaborane(11). Acta Crystallogr C (2001) 1.21

Fine-needle aspiration biopsy in pancreatic transplantation. Transplant Proc (1995) 1.21